Showing results (41-50 of 92) with videos related to
Sort By:
Pageof 10
Plos Currents|December 6, 2011
Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD StudyRay Dorsey, Kevin Biglan, Shirley Eberly, et al.Movement Disorders Clinical Practice|October 27, 2018
Early Clinical Predictors of Treatment-Resistant and Functional Outcomes in Parkinson's DiseaseRoger Kurlan, Bernard Ravina, Shirley Eberly, et al.American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 15, 2010
In their own words: reports of stigma and genetic discrimination by people at risk for Huntington disease in the International RESPOND-HD studyJanet K Williams, Cheryl Erwin, Andrew R Juhl, et al.Annals of Neurology|July 12, 2002
Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trialIra Shoulson, David Oakes, Stanley Fahn, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 2, 2006
Rasagiline improves quality of life in patients with early Parkinson's diseaseKevin M Biglan, Steven Schwid, Shirley Eberly, et al.Pharmacogenetics and Genomics|January 10, 2014
Pharmacogenomic characterization of gemcitabine response--a framework for data integration to enable personalized medicineMichael Harris, Krithika Bhuvaneshwar, Thanemozhi Natarajan, et al.Archives of Neurology|December 10, 2008
Communicating clinical trial results to research participantsE Ray Dorsey, Christopher A Beck, Mary Adams, et al.Journal of Huntington'S Disease|July 27, 2014
Depressed mood and suicidality in individuals exposed to tetrabenazine in a large Huntington disease observational studyE Ray Dorsey, Alicia F D Brocht, Paige E Nichols, et al.American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 15, 2010
Perception, experience, and response to genetic discrimination in Huntington disease: the international RESPOND-HD studyCheryl Erwin, Janet K Williams, Andrew R Juhl, et al.Annals of Clinical and Translational Neurology|June 8, 2017
A novel design of a Phase III trial of isradipine in early Parkinson disease (STEADY-PD III)Kevin M Biglan, David Oakes, Anthony E Lang, et al.Pageof 10